MOUNTAIN VIEW, Calif., Dec. 12, 2024 /PRNewswire/ -- Corvus Robotics, a provider of autonomous inventory management systems, today announced that it has recruited Rob Stevens, former VP of ...
Corvus Pharmaceuticals (NASDAQ:CRVS) lost ~34% in the premarket on Wednesday after the company announced early results from a Phase 1 trial for its lead asset, soquelitinib, in patients with ...
(RTTNews) - Corvus Pharmaceuticals Inc. (CRVS), a clinical-stage biopharmaceutical company, is scheduled to announce interim data from its Phase 1 trial of Soquelitinib in moderate to severe ...
Corvus Pharmaceuticals' stock plummeted ~40% after Phase 1 data for soquelitinib in atopic dermatitis showed mixed results, raising concerns about its efficacy. Phase 1 data for soquelitinib in AD ...
Corvus Integration is pleased to announce the release of the Corvus Tetrad - a modified version of the Corvus Sleeve biometric solution that utilises the new ...
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) released interim data from a Phase 1 trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis. The trial will enroll 64 ...
FaceCube will be featured in exhibits hosted by IBM and Dev Technology at this year’s GIS The Corvus Integration FaceCube will be featured in exhibits hosted by IBM (Corvus’ biometrics services ...